Effects of Apolipoprotein E Polymorphism on Cerebral Oxygen Saturation After Traumatic Brain Injury

Objective: To investigate the effects of the apolipoprotein E gene (APOE) on the cerebral oxygen saturation of patients after traumatic brain injury (TBI). Methods: Clinical data of 114 patients with TBI and 54 normal people were collected. The APOE genotypes of all subjects were determined by quant...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in neurology 2020-11, Vol.11, p.539627-539627
Hauptverfasser: Wu, Zhimin, Xiong, Senjie, Sun, Xiaochuan, Shi, Quanhong, Dan, Wei, Zhan, Yan, Xie, Yanfeng, Jiang, Li
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective: To investigate the effects of the apolipoprotein E gene (APOE) on the cerebral oxygen saturation of patients after traumatic brain injury (TBI). Methods: Clinical data of 114 patients with TBI and 54 normal people were collected. The APOE genotypes of all subjects were determined by quantitative fluorescent polymerase chain reaction (QF-PCR). The regional cerebral oxygen saturation (rScO 2 ) of TBI patients and normal people were monitored by near-infrared spectroscopy (NIRS). Results: The mean rScO 2 of patients was (55.06 ± 7.60)% in the early stage of TBI, which was significantly lower than that of normal people (67.21 ± 7.80)% ( P < 0.05). Single-factor and multifactor logistic regression analyses showed APOEε4 was an independent risk factor that caused the early decline of rScO2 in TBI patients. Furthermore, in the TBI group, the rScO 2 of APOEε4 carriers (52.23 ± 8.02)% was significantly lower than that of non-ε4 carriers (60.33 ± 7.12)% ( P < 0.05). But in the normal group, no significant differences in rScO 2 were found between APOEε4 carriers and non-carriers. Conclusion: The rScO 2 may be significantly decreased after TBI, and APOEε4 may be a risk factor for decreased rScO 2 in the early stage of TBI.
ISSN:1664-2295
1664-2295
DOI:10.3389/fneur.2020.539627